Statins Have No Additional Benefit for Pulmonary Hypertension: A Meta-Analysis of Randomized Controlled Trials.

PLoS One · 2016 · PMC5167271 · PMID 27992469

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

PH due to COPD The two studies involving PH due to COPD [ 12 , 19 ] used different parameters as endpoints from each other, leaving SPAP as the only data for meta-analysis, which showed a trend to decrease but no significant difference between statins and control groups (MD = -4.87 [CI: -13.05 to 3.32], Fig 4 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.